Literature DB >> 32193562

[Pain management in osteoporosis].

L Heuchemer1, D Emmert1, T Bender1, T Rasche1, M Marinova2, A Kasapovic3, R Conrad4, M Mücke5.   

Abstract

Osteoporosis is a very common disease all over the world, in which a reduction in bone density can lead to an increased risk of fractures and a diminished physical height. Osteoporosis is also associated with acute and chronic pain, which especially occurs in the back and can significantly reduce the quality of life. To provide sufficient care for affected patients, it is essential to know the particularities of pain management in osteoporosis, such as pharmacological and nonpharmacological treatment options. This article gives a comprehensive review of pain management in osteoporosis and also explains the underlying pathomechanisms, risk factors, and diagnostic procedures.

Entities:  

Keywords:  Absorptiometry, dual-energy x‑ray; Analgesics, opioid; Bisphosphonates; Fracture risk; Physical therapy modalities

Mesh:

Substances:

Year:  2020        PMID: 32193562     DOI: 10.1007/s00132-020-03898-5

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  24 in total

1.  Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration.

Authors:  S Scharla; H Oertel; K Helsberg; F Kessler; F Langer; T Nickelsen
Journal:  Curr Med Res Opin       Date:  2006-12       Impact factor: 2.580

2.  Endocrine effects of chronic opioid therapy: implications for clinical management.

Authors:  Jennifer A Elliott; Eugene E Fibuch
Journal:  Pain Manag       Date:  2013-05

3.  Yoga spinal flexion positions and vertebral compression fracture in osteopenia or osteoporosis of spine: case series.

Authors:  Mehrsheed Sinaki
Journal:  Pain Pract       Date:  2012-03-26       Impact factor: 3.183

Review 4.  Bone pain mechanism in osteoporosis: a narrative review.

Authors:  Consalvo Mattia; Flaminia Coluzzi; Ludovica Celidonio; Renato Vellucci
Journal:  Clin Cases Miner Bone Metab       Date:  2016-10-05

5.  Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS).

Authors:  P Vestergaard; P Hermann; J-E B Jensen; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2011-06-28       Impact factor: 4.507

6.  [Clinical value of urinary pyridinium crosslinks as osteoporosis markers: evaluation of a population survey of vertebral osteoporosis].

Authors:  A Behre; J Janott; M Pfohl; H Schatz; A Pfeiffer
Journal:  Med Klin (Munich)       Date:  2001-07-15

7.  Use of bisphosphonates and risk of postmenopausal breast cancer.

Authors:  Gad Rennert; Mila Pinchev; Hedy S Rennert
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

Review 8.  [Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain].

Authors:  W Häuser; F Bock; P Engeser; G Hege-Scheuing; M Hüppe; G Lindena; C Maier; H Norda; L Radbruch; R Sabatowski; M Schäfer; M Schiltenwolf; M Schuler; H Sorgatz; T Tölle; A Willweber-Strumpf; F Petzke
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

Review 9.  Osteoporosis in women with disabilities.

Authors:  Sarina Schrager
Journal:  J Womens Health (Larchmt)       Date:  2004-05       Impact factor: 2.681

Review 10.  Management of chronic pain in osteoporosis: challenges and solutions.

Authors:  Teresa Paolucci; Vincenzo Maria Saraceni; Giulia Piccinini
Journal:  J Pain Res       Date:  2016-04-01       Impact factor: 3.133

View more
  1 in total

1.  How relevant is lumbar bone mineral density for the stability of symphyseal implants? A biomechanical cadaver study.

Authors:  Fanny Schwaabe; Johannes Gleich; Christoph Linhart; Alexander Martin Keppler; Matthias Woiczinski; Christian Kammerlander; Axel Greiner; Wolfgang Böcker; Adrian Cavalcanti Kußmaul
Journal:  Eur J Trauma Emerg Surg       Date:  2021-12-08       Impact factor: 2.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.